“…The metabolic conditions of subjects included in the studies were moderate hypercholesterolemia [ 21 , 22 ], mildly dyslipidemia [ 23 ], hyperlipidemia [ 20 ], hypercholesterolemia [ 24 , 25 , 26 , 27 ], hiperlipidemia [ 28 ], dyslipidemia [ 29 ], mildly hypercholesterolemia [ 30 , 31 ], dyslipidemia with hypertension [ 32 , 33 , 34 ], and healthy subjects as a control group [ 25 , 27 ]. The studies designs included seven randomized trial [ 26 , 28 , 29 , 30 , 31 , 34 ], six with randomized crossover trial [ 21 , 23 , 25 , 27 , 33 ], and three evaluation of baseline and post intervention [ 20 , 24 ]. The studies were conducted in Brazil [ 29 , 32 , 33 , 35 ], Iran [ 20 , 26 , 28 , 34 ], Spain [ 21 , 27 ], China [ 24 , 31 ], Korea [ 30 ], Greece [ 25 ], United Stated of America [ 22 ], and Italy [...…”